Molecular Networking Reveals Two Distinct Chemotypes in Pyrroloiminoquinone-Producing Tsitsikamma favus Sponges.

Abstract

The temperate marine sponge, Tsitsikamma favus, produces pyrroloiminoquinone alkaloids with potential as anticancer drug leads. We profiled the secondary metabolite reservoir of T. favus sponges using HR-ESI-LC-MS/MS-based molecular networking analysis followed by preparative purification efforts to map the diversity of new and known pyrroloiminoquinones and related compounds in extracts of seven specimens. Molecular taxonomic identification confirmed all sponges as T. favus and five specimens (chemotype I) were found to produce mainly discorhabdins and tsitsikammamines. Remarkably, however, two specimens (chemotype II) exhibited distinct morphological and chemical characteristics: the absence of discorhabdins, only trace levels of tsitsikammamines and, instead, an abundance of unbranched and halogenated makaluvamines. Targeted chromatographic isolation provided the new makaluvamine Q, the known makaluvamines A and I, tsitsikammamine B, 14-bromo-7,8-dehydro-3-dihydro-discorhabdin C, and the related pyrrolo-ortho-quinones makaluvamine O and makaluvone. Purified compounds displayed different activity profiles in assays for topoisomerase I inhibition, DNA intercalation and antimetabolic activity against human cell lines. This is the first report of makaluvamines from a Tsitsikamma sponge species, and the first description of distinct chemotypes within a species of the Latrunculiidae family. This study sheds new light on the putative pyrroloiminoquinone biosynthetic pathway of latrunculid sponges.

• Authors: Jarmo-Charles J Kalinski, Samantha C Waterworth, Xavier Siwe Noundou, Meesbah Jiwaji, Shirley Parker-Nance, Rui W M Krause, Kerry L McPhail, Rosemary A Dorrington
• Journal: Marine drugs (Mar Drugs) Vol. 17 Issue 1 (Jan 16 2019) ISSN: 1660-3397 [Electronic] Switzerland
• PMID: 30654589 (Publication Type: Journal Article)

Chemical References

• Antimetabolites, Antineoplastic
• Intercalating Agents
• Pyrroloiminoquinones
• Topoisomerase I Inhibitors
• DNA
• DNA Topoisomerases, Type I
• TOP1 protein, human

Topics

• Animals
• Antimetabolites, Antineoplastic (chemistry, isolation & purification, pharmacology)
• Biosynthetic Pathways
• Cell Survival (drug effects)
• Chromatography, High Pressure Liquid (methods)
• DNA (chemistry, drug effects)
• DNA Topoisomerases, Type I (metabolism)
• Enzyme Assays
• HEK293 Cells
• HeLa Cells
• Humans
• Intercalating Agents (chemistry, isolation & purification, pharmacology)
• Molecular Structure
• Porifera (metabolism)
• Pyrroloiminoquinones (chemistry, isolation & purification, metabolism, pharmacology)
• Tandem Mass Spectrometry (methods)
• Topoisomerase I Inhibitors (chemistry, isolation & purification, metabolism, pharmacology)